CATALYST PHARMACEUTICALS INC's ticker is CPRX and the CUSIP is 14888U101. A total of 118 filers reported holding CATALYST PHARMACEUTICALS INC in Q3 2019. The put-call ratio across all filers is 3.27 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,999,084 | +57.0% | 171,008 | +80.5% | 0.01% | +66.7% |
| Q2 2023 | $1,273,359 | +86.1% | 94,744 | +129.6% | 0.00% | +50.0% |
| Q1 2023 | $684,190 | -10.9% | 41,266 | -0.1% | 0.00% | 0.0% |
| Q4 2022 | $767,994 | +19099.8% | 41,290 | +19561.9% | 0.00% | – |
| Q3 2022 | $4,000 | -50.0% | 210 | -80.1% | 0.00% | – |
| Q2 2022 | $8,000 | -99.9% | 1,053 | -99.8% | 0.00% | -100.0% |
| Q1 2022 | $5,442,000 | +22.2% | 656,372 | -0.2% | 0.01% | +50.0% |
| Q4 2021 | $4,452,000 | +27.8% | 657,454 | +0.0% | 0.01% | +14.3% |
| Q3 2021 | $3,483,000 | -3.4% | 657,239 | +4.8% | 0.01% | 0.0% |
| Q2 2021 | $3,605,000 | +24.7% | 626,997 | +0.0% | 0.01% | +16.7% |
| Q1 2021 | $2,890,000 | +36.9% | 626,878 | -0.8% | 0.01% | +50.0% |
| Q4 2020 | $2,111,000 | +12.3% | 631,851 | -0.2% | 0.00% | 0.0% |
| Q3 2020 | $1,879,000 | -27.3% | 632,832 | +13.1% | 0.00% | -33.3% |
| Q2 2020 | $2,585,000 | +157.2% | 559,447 | +114.2% | 0.01% | +100.0% |
| Q1 2020 | $1,005,000 | +2771.4% | 261,196 | +2695.9% | 0.00% | – |
| Q4 2019 | $35,000 | -94.6% | 9,342 | -92.4% | 0.00% | -100.0% |
| Q3 2019 | $652,000 | +9214.3% | 122,717 | +6219.1% | 0.00% | – |
| Q2 2019 | $7,000 | +250.0% | 1,942 | +225.3% | 0.00% | – |
| Q4 2017 | $2,000 | -100.0% | 597 | -100.0% | 0.00% | -100.0% |
| Q1 2016 | $5,957,000 | -46.9% | 5,091,120 | +11.1% | 0.02% | -50.0% |
| Q4 2015 | $11,227,000 | -18.3% | 4,582,320 | 0.0% | 0.04% | -18.2% |
| Q3 2015 | $13,747,000 | -27.1% | 4,582,320 | +0.4% | 0.04% | -22.8% |
| Q2 2015 | $18,848,000 | +119.3% | 4,563,800 | +129.9% | 0.06% | +119.2% |
| Q1 2015 | $8,595,000 | +101.7% | 1,985,000 | +38.3% | 0.03% | +100.0% |
| Q4 2014 | $4,262,000 | -57.9% | 1,435,000 | -52.9% | 0.01% | -60.6% |
| Q3 2014 | $10,121,000 | +25.6% | 3,048,500 | -4.3% | 0.03% | +32.0% |
| Q2 2014 | $8,058,000 | +9.1% | 3,185,000 | -2.5% | 0.02% | 0.0% |
| Q1 2014 | $7,384,000 | +16.3% | 3,267,000 | +0.4% | 0.02% | +13.6% |
| Q4 2013 | $6,347,000 | -36.7% | 3,254,960 | -0.9% | 0.02% | -43.6% |
| Q3 2013 | $10,020,000 | +179.1% | 3,285,000 | -18.6% | 0.04% | +178.6% |
| Q2 2013 | $3,590,000 | – | 4,034,207 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANAKA CAPITAL MANAGEMENT INC | 148,281 | $2,458 | 7.14% |
| GABLES CAPITAL MANAGEMENT INC. | 409,080 | $6,782,546 | 4.74% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 10,355,099 | $171,687,541 | 3.83% |
| JW Asset Management, LLC | 563,392 | $9,341,039 | 3.58% |
| Quantedge Capital Pte Ltd | 324,700 | $5,383,526 | 2.10% |
| Paradiem, LLC | 236,628 | $3,923,292 | 1.22% |
| SummerHaven Investment Management, LLC | 100,592 | $1,667,815 | 0.97% |
| Capital Impact Advisors, LLC | 46,096 | $764,272 | 0.94% |
| Yorktown Management & Research Co Inc | 50,000 | $829,000 | 0.89% |
| Seaport Global Advisors, LLC | 15,598 | $258,615 | 0.82% |